Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Hiroyuki, Murai"'
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis
Autor:
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P. Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 5, Pp 1338-1346 (2024)
Abstract Objective Eculizumab and ravulizumab are complement protein C5 inhibitors, showing efficacy and tolerability for patients with anti‐acetylcholine receptor‐positive (AChR+) generalized myasthenia gravis (gMG) in phase 3 clinical trials an
Externí odkaz:
https://doaj.org/article/4435d7c8136845bebdde0611ea441e42
Autor:
Toshiaki Nonaka, Ryusuke Ae, Koki Kosami, Hiroya Tange, Miho Kaneko, Takehiro Nakagaki, Tsuyoshi Hamaguchi, Nobuo Sanjo, Yoshikazu Nakamura, Tetsuyuki Kitamoto, Yoshiyuki Kuroiwa, Kensaku Kasuga, Manabu Doyu, Fumiaki Tanaka, Koji Abe, Shigeo Murayama, Ichiro Yabe, Hideki Mochizuki, Takuya Matsushita, Hiroyuki Murai, Masashi Aoki, Koji Fujita, Masafumi Harada, Masaki Takao, Tadashi Tsukamoto, Yasushi Iwasaki, Masahito Yamada, Hidehiro Mizusawa, Katsuya Satoh, Noriyuki Nishida
Publikováno v:
Diagnostics, Vol 14, Iss 21, p 2424 (2024)
Background/Objectives: Sporadic Creutzfeldt–Jakob disease (sCJD) is a fatal neurodegenerative disorder traditionally diagnosed based on the World Health Organization (WHO) criteria in 1998. Recently, Hermann et al. proposed updated diagnostic crite
Externí odkaz:
https://doaj.org/article/1d7e4d35198745628c5f312cf6064510
Autor:
Koki Suezumi, Taira Uehara, Akihiko Taira, Naoki Akamatsu, Tatsuya Tanaka, Yuichiro Hayashi, Mina Komuta, Takayuki Shiomi, Hiroyuki Murai
Publikováno v:
eNeurologicalSci, Vol 34, Iss , Pp 100490- (2024)
Externí odkaz:
https://doaj.org/article/dce68bec551a4f47b7fbd9c64389642c
Autor:
James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric, Jan L. De Bleecker, Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Mamatha Pasnoor, Antonio Guglietta, Benjamin Van Hoorick, Sophie Steeland, Caroline T’joen, Kimiaki Utsugisawa, Jan Verschuuren, Renato Mantegazza, the ADAPT+ Study Group
Publikováno v:
Frontiers in Neurology, Vol 14 (2024)
ObjectiveADAPT+ assessed the long-term safety, tolerability, and efficacy of efgartigimod in adult participants with generalized myasthenia gravis (gMG).MethodsADAPT+ was an open-label, single-arm, multicenter, up to 3-year extension of the pivotal p
Externí odkaz:
https://doaj.org/article/1a89a0788ce640369ff168f37dc4e637
Autor:
Tomoko Narita, Shunya Nakane, Akiko Nagaishi, Naoya Minami, Masaaki Niino, Naoki Kawaguchi, Hiroyuki Murai, Jun-ichi Kira, Jun Shimizu, Kazuo Iwasa, Hiroaki Yoshikawa, Yuki Hatanaka, Masahiro Sonoo, Yuko Shimizu, Hidenori Matsuo
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: Treatment for ocular myasthenia gravis (OMG) has not yet been well established. Few reports have been published on the clinical practice and outcomes of OMG. Objectives: We investigated treatment of OMG and its outcomes in Japan. Design:
Externí odkaz:
https://doaj.org/article/4502b9f6815f4854ba27c57f2bfaf18c
Autor:
Jacqueline Palace, Kristl G Claeys, Renato Mantegazza, Andreas Meisel, Casey Quinn, Srikanth Muppidi, Hiroyuki Murai, Francesco Saccà, Sonia Berrih-Aknin, Sarah Dewilde, Mark Larkin, Jon Beauchamp, Sandra Paci, Laura Day, Glenn Philips, Silvia Chiroli, Guillaume Bassez, MF Janssen
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Objectives Myasthenia gravis (MG) is a rare, chronic, autoimmune neuromuscular disease which can affect functional and mental aspects of health and health-related quality of life (HRQoL). This study aims to obtain detailed knowledge of the impact of
Externí odkaz:
https://doaj.org/article/89526dac77d5406291833a31dcc90782
Autor:
Yutaka Furukawa, Satoshi Kuwabara, Nagato Kuriyama, Yoshiko Nomura, Yasunari Sakai, Makoto Matsui, Yosikazu Nakamura, Hiroyuki Murai, Yumi Adachi, Hiroaki Yoshikawa, Kazuo Iwasa
Publikováno v:
BMJ Neurology Open, Vol 4, Iss 2 (2022)
Background There was no nationwide epidemiological study of Lambert-Eaton myasthenic syndrome (LEMS) in Japan; therefore, we conducted a nationwide survey.Methods For the first survey, we sent survey sheets to randomly selected medical departments (n
Externí odkaz:
https://doaj.org/article/0cee86ab7a774249a6bd5e99775ad7bc
Autor:
Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Takahashi, Masanori P., Hiroyuki Murai, Kimiaki Utsugisawa
Publikováno v:
Neurology: Clinical Practice; Jun2024, Vol. 14 Issue 3, p1-9, 9p
Autor:
Tsuyoshi Hamaguchi, Kenji Sakai, Atsushi Kobayashi, Tetsuyuki Kitamoto, Ryusuke Ae, Yosikazu Nakamura, Nobuo Sanjo, Kimihito Arai, Mizuho Koide, Fumiaki Katada, Masafumi Harada, Hiroyuki Murai, Shigeo Murayama, Tadashi Tsukamoto, Hidehiro Mizusawa, Masahito Yamada
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 6, Pp 1140-1146 (2020)
We previously reported a phenotype of Creutzfeldt-Jakob disease (CJD), CJD-MMiK, that could help identify iatrogenic CJD. To find cases mimicking CJD-MMiK, we investigated clinical features and pathology of 1,155 patients with diagnosed sporadic CJD
Externí odkaz:
https://doaj.org/article/e01bab45d45544ab94e2a6acc9cfaa65
Autor:
Hiroaki Yoshikawa, Yumi Adachi, Yosikazu Nakamura, Nagato Kuriyama, Hiroyuki Murai, Yoshiko Nomura, Yasunari Sakai, Kazuo Iwasa, Yutaka Furukawa, Satoshi Kuwabara, Makoto Matsui
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Objective To study the updated prevalence and clinical features of myasthenia gravis (MG) in Japan during 2017. Methods We sent survey sheets to the randomly selected medical departments (number = 7,545). First, we asked the number of MG patients who
Externí odkaz:
https://doaj.org/article/ac39d27ace3e4023acc4dd82370a8de1